JACC: Heart Failure - Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m2
Release Date:
Anju Bhardwaj, MD, social media editor of JACC: Heart Failure, discusses a recently published original research paper assessing the safety and efficacy of continuing sacubitril/valsartan in patients with deterioration of kidney function below an eGFR of 30 mL/min/1.73 m2.
JACC: Heart Failure - Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m2